GlassScriptPhysician profile
Robert Christopher Lawler
NPI 1386758506
$3,312.81
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.18 · 2020: $249 · 2021: $1,294 · 2022: $1,082 · 2023: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $710.50 | 2020-2023 | |
| Amgen INC. | $497.82 | 2020-2023 | Prolia, Evenity |
| Novo Nordisk INC | $464.77 | 2020-2023 | Wegovy |
| Astellas Pharma US INC | $248.47 | 2021-2023 | Myrbetriq |
| Teva Pharmaceuticals USA, INC. | $165.84 | 2020-2021 | |
| Coopersurgical, INC. | $142.87 | 2021-2022 | |
| Medtronic, INC. | $127.38 | 2023 | Signia |
| Avion Pharmaceuticals | $117.64 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $88.65 | 2023 | Myfembree |
| Myovant Sciences INC. | $86.84 | 2022 | |
| Aspira Women'S Health INC | $85.18 | 2021-2022 | |
| Pfizer INC. | $81.13 | 2021-2023 | |
| Dexcom, INC. | $80.95 | 2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $78.39 | 2020-2021 | |
| Hologic Sales and Service, LLC | $53.44 | 2021-2023 | Aptima, Affirm Prone Biopsy System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $47.77 | 2021 | |
| Currax Pharmaceuticals LLC | $37.93 | 2021-2022 | |
| Therapeuticsmd, INC. | $22.13 | 2021 | |
| Acessa Health INC. | $20.18 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.42 | 2021 | |
| Channel Medsystems, INC. | $18.27 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.76 | 2022 | |
| Amag Pharmaceuticals, INC. | $16.39 | 2022 | |
| Exeltis, USA INC. | $14.16 | 2021 | |
| Eisai INC. | $13.49 | 2021 | |
| Gynesonics, INC. | $13.37 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bausch Health US, LLC | $13.18 | 2021 | |
| Dysis Medical, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lawler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.